Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model ; volume:47 ; number:6 ; year:2018 ; pages:2233-2249
Cellular physiology and biochemistry ; 47, Heft 6 (2018), 2233-2249
- Urheber
-
Lee, Sungmin
Son, Beomseok
Jeon, Jaewan
Park, Gaeul
Kim, Hyunwoo
Kang, Hyunkoo
Youn, HyeSook
Jo, Sunmi
Song, Jie-Young
Youn, BuHyun
- DOI
-
10.1159/000491535
- URN
-
urn:nbn:de:101:1-2018080200320474102187
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Sungmin
- Son, Beomseok
- Jeon, Jaewan
- Park, Gaeul
- Kim, Hyunwoo
- Kang, Hyunkoo
- Youn, HyeSook
- Jo, Sunmi
- Song, Jie-Young
- Youn, BuHyun
Ähnliche Objekte (12)
Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
Melatonin: a potential intervention for hepatic steatosis
Betaine in ameliorating alcohol-induced hepatic steatosis
Role of SCAP/SREBP in Hepatic Steatosis
Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
Melatonin: a potential intervention for hepatic steatosis
Betaine in ameliorating alcohol-induced hepatic steatosis
Role of SCAP/SREBP in Hepatic Steatosis
Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
Melatonin: a potential intervention for hepatic steatosis
Betaine in ameliorating alcohol-induced hepatic steatosis
Role of SCAP/SREBP in Hepatic Steatosis